Case Study: Global Pharmaceutical Company achieves rapid threat detection, full attack context and 90% fewer re-imaging incidents with Cybereason

Global Pharmaceutical Company Fills its Detection and Remediation Gaps

Global Pharmaceutical Company, one of the world’s largest pharmaceutical firms, was struggling with limited endpoint visibility and repeated breaches despite top-tier antivirus, SIEM and network tools. The security team couldn’t identify the source, severity or scope of advanced and never-before-seen threats, so the company engaged Cybereason and deployed the Cybereason platform (endpoint detection and response and the Incident and Response Console) to gain continuous endpoint insight and attack context.

Cybereason was rolled out on 4,000 endpoints and immediately detected several signature-based threats the incumbent antivirus missed, linked behaviors to reveal novel attacks, and gave analysts full attack context to remediate incidents—often in fewer than 10 hours. As a result, re-imaging fell by 90%, the team’s ability to understand attack context rose from 35% to over 90%, IT time and business interruptions were dramatically reduced, and the platform was rapidly expanded to thousands more endpoints to contain and analyze additional infections.